Found: 38
Select item for more details and to access through your institution.
Interobserver variability in the radiological assessment of magnetic resonance imaging (MRI) including perfusion MRI in glioblastoma multiforme.
- Published in:
- European Journal of Neurology, 2016, v. 23, n. 10, p. 1528, doi. 10.1111/ene.13070
- By:
- Publication type:
- Article
Development and psychometric evaluation of item banks for memory and attention – supplements to the EORTC CAT Core instrument.
- Published in:
- Health & Quality of Life Outcomes, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12955-023-02199-7
- By:
- Publication type:
- Article
Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.
- Published in:
- Clinical Rheumatology, 2013, v. 32, n. 5, p. 585, doi. 10.1007/s10067-012-2136-8
- By:
- Publication type:
- Article
P14.49 Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii47, doi. 10.1093/neuonc/noab180.162
- By:
- Publication type:
- Article
P14.01 Incidence and impact of venous thromboembolism and major bleeding in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii38, doi. 10.1093/neuonc/noab180.130
- By:
- Publication type:
- Article
P12.01 The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii30, doi. 10.1093/neuonc/noab180.103
- By:
- Publication type:
- Article
P09.04 T<sub>2</sub> hyperintense regions on MRI in gliomas: a comparison between routine clinical MRI and 7T MRI.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii27, doi. 10.1093/neuonc/noab180.092
- By:
- Publication type:
- Article
P04.10 CDKN2A mutational status is associated with venous thromboembolism in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii20, doi. 10.1093/neuonc/noab180.067
- By:
- Publication type:
- Article
OS10.8.A The effectiveness of antiepileptic drug duotherapies in glioma patients: a multicenter observational cohort study.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii14, doi. 10.1093/neuonc/noab180.046
- By:
- Publication type:
- Article
OS05.4.A Do neurocognitive deficits explain the differences between brain tumour patients and their proxies assessing the patient's I-ADL?
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii7, doi. 10.1093/neuonc/noab180.021
- By:
- Publication type:
- Article
PL03.4.A Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii2, doi. 10.1093/neuonc/noab180.006
- By:
- Publication type:
- Article
OS10.1 Survival analysis of IDH wildtype astrocytomas with molecular features of glioblastoma, WHO grade IV.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii20, doi. 10.1093/neuonc/noz126.067
- By:
- Publication type:
- Article
OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM).
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii14, doi. 10.1093/neuonc/noz126.047
- By:
- Publication type:
- Article
OS7.1 Impact of the addition of Rituximab to standard therapy with high dose methotrexate on health-related quality of life in primary central nervous system lymphoma patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii13, doi. 10.1093/neuonc/noz126.044
- By:
- Publication type:
- Article
OS7.2 Measuring change in health-related quality of life: the added value of analysis on the individual patient level in glioma patients in clinical decision making.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii14, doi. 10.1093/neuonc/noz126.045
- By:
- Publication type:
- Article
OS3.6 Prediagnostic symptoms and signs of adult glioma: the patients' view.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.030
- By:
- Publication type:
- Article
OS3.5 Prescription medications in glioma patients and the prevalence of depression, anxiety and subjective cognitive impairment.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.029
- By:
- Publication type:
- Article
OS3.3 Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii9, doi. 10.1093/neuonc/noz126.027
- By:
- Publication type:
- Article
OS3.1 Antiepileptic drugs and their association with depression, anxiety and subjective cognitive impairment in glioma patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii8, doi. 10.1093/neuonc/noz126.025
- By:
- Publication type:
- Article
P05.65 The caregiver burden in meningioma: long-term results and its effects on caregiver's health-related quality of life, anxiety and depression.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii318, doi. 10.1093/neuonc/noy139.391
- By:
- Publication type:
- Article
P05.78 Improving quality of care of meningioma patients: initial evaluation of issues in care trajectories according to the Plan-Do-Study-Act Cycle.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii321, doi. 10.1093/neuonc/noy139.404
- By:
- Publication type:
- Article
P05.64 The disease burden of meningioma patients: long-term results on work productivity and healthcare consumption.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii318, doi. 10.1093/neuonc/noy139.390
- By:
- Publication type:
- Article
P01.093 The level of reporting of neurocognitive outcomes in randomized controlled trials of brain tumour patients: a systematic review.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii252, doi. 10.1093/neuonc/noy139.135
- By:
- Publication type:
- Article
P01.079 Determining the content validity of measures of basic and instrumental activities of daily living (ADL) in patients with brain tumours, a systematic review.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii248, doi. 10.1093/neuonc/noy139.121
- By:
- Publication type:
- Article
P01.049 Prediagnostic presentations of glioma in primary care: a case-control study.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii240, doi. 10.1093/neuonc/noy139.091
- By:
- Publication type:
- Article
P01.042 Symptom clusters in newly diagnosed glioma patients: which clusters are associated with functioning and global health status?.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii238, doi. 10.1093/neuonc/noy139.084
- By:
- Publication type:
- Article
OS4.6 Does radiation target volume affect health-related quality of life in patients with low grade glioma on the short-term? - a secondary analysis of the EORTC 22033–26033 trial.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii223, doi. 10.1093/neuonc/noy139.031
- By:
- Publication type:
- Article
OS4.2 The long-term disease burden of meningioma patients: results on health-related quality of life, cognitive function, anxiety and depression.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii222, doi. 10.1093/neuonc/noy139.027
- By:
- Publication type:
- Article
O9.05 COGNITIVE FUNCTIONING, HEALTH-RELATED QUALITY OF LIFE AND SURVIVAL AFTER STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH BRAIN METASTASES.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii21, doi. 10.1093/neuonc/nou174.76
- By:
- Publication type:
- Article
O9.08 END OF LIFE CARE IN HIGH-GRADE GLIOMA PATIENTS IN THREE EUROPEAN COUNTRIES: A COMPARATIVE STUDY.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii22, doi. 10.1093/neuonc/nou174.79
- By:
- Publication type:
- Article
P15.04 DEVELOPMENT OF A NEW QUESTIONNAIRE TO MEASURE INSTRUMENTAL ACTIVITIES OF DAILY LIVING (I-ADL) IN PATIENTS WITH PRIMARY BRAIN TUMOURS: RESULTS OF PHASE 1.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii74, doi. 10.1093/neuonc/nou174.283
- By:
- Publication type:
- Article
Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: Bone mineral density measurements in a multicenter randomized clinical trial.
- Published in:
- Arthritis Care & Research, 2011, v. 63, n. 12, p. 1691, doi. 10.1002/acr.20612
- By:
- Publication type:
- Article
Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 463, doi. 10.1007/s11060-019-03117-y
- By:
- Publication type:
- Article
Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 133, doi. 10.1007/s11060-018-2779-7
- By:
- Publication type:
- Article
Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 132, n. 1, p. 145, doi. 10.1007/s11060-016-2352-1
- By:
- Publication type:
- Article
Symptoms and medication management in the end of life phase of high-grade glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 120, n. 3, p. 589, doi. 10.1007/s11060-014-1591-2
- By:
- Publication type:
- Article
End of life care in high-grade glioma patients in three European countries: a comparative study.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 120, n. 2, p. 303, doi. 10.1007/s11060-014-1548-5
- By:
- Publication type:
- Article